Literature DB >> 30069411

A case of maoto-induced interstitial pneumonia.

Masaru Ando1, Taiki Masuda1, Mari Yamasue1, Shin-Ichi Nureki1, Eishi Miyazaki2, Jun-Ichi Kadota1.   

Abstract

A 64-year-old man was prescribed maoto, a prevailing Chinese herbal, for a cold with upper respiratory inflammation. Two days later, he developed a high fever, progressive dyspnea and pulmonary infiltration on chest high-resolution computed tomography (HRCT) including diffuse ground-glass opacity mainly around bronchovascular bundles and partial distribution of subpleural cysts resembling honeycombing. Despite the administration of azithromycin and pazufloxacin, the pulmonary infiltration and hypoxemia has rapidly progressed, so he was referred to our hospital. Although fulminant pneumonia or the acute exacerbation of idiopathic pulmonary fibrosis (IPF) was considered, his respiratory symptoms and pulmonary infiltration immediately improved and oxygen therapy was not needed on the fifth hospital day. Based on the clinical course, laboratory findings and the chest imaging findings, drug induced interstitial lung disease was suspected. The drug-induced lymphocyte test (DLST) as well as a scratch test against maoto demonstrated positive results. This is the first case report of maoto-induced interstitial pneumonia that was diagnosed based on the patient's clinical course, chest imaging findings and laboratory findings.

Entities:  

Keywords:  Maoto; acute exacerbation of idiopathic pulmonary fibrosis (IPF); drug induced interstitial lung disease

Year:  2018        PMID: 30069411      PMCID: PMC6051839          DOI: 10.21037/jtd.2018.05.82

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  12 in total

1.  Drug-induced lymphocyte stimulation test is not useful for the diagnosis of drug-induced pneumonia.

Authors:  Osamu Matsuno; Toshiyuki Okubo; Shigeo Hiroshige; Rhyuichi Takenaka; Emiko Ono; Takuya Ueno; Shinichi Nureki; Masaru Ando; Eishi Miyazaki; Toshihide Kumamoto
Journal:  Tohoku J Exp Med       Date:  2007-05       Impact factor: 1.848

2.  In vitro tests of T cell-mediated drug hypersensitivity.

Authors:  Andreas Beeler; Werner J Pichler
Journal:  Expert Rev Clin Immunol       Date:  2006-11       Impact factor: 4.473

Review 3.  Current status of DILD in molecular targeted therapies.

Authors:  Yoshinobu Saito; Akihiko Gemma
Journal:  Int J Clin Oncol       Date:  2012-11-15       Impact factor: 3.402

4.  The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity.

Authors:  B Nyfeler; W J Pichler
Journal:  Clin Exp Allergy       Date:  1997-02       Impact factor: 5.018

5.  A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.

Authors:  Shigeki Nabeshima; Kenichiro Kashiwagi; Kazuhiko Ajisaka; Shinta Masui; Hiroaki Takeoka; Hideyuki Ikematsu; Seizaburo Kashiwagi
Journal:  J Infect Chemother       Date:  2012-02-16       Impact factor: 2.211

6.  Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.

Authors:  Y Kano; K Hirahara; Y Mitsuyama; R Takahashi; T Shiohara
Journal:  Allergy       Date:  2007-12       Impact factor: 13.146

Review 7.  Interstitial lung disease induced by drugs and radiation.

Authors:  Philippe Camus; Annlyse Fanton; Philippe Bonniaud; Clio Camus; Pascal Foucher
Journal:  Respiration       Date:  2004 Jul-Aug       Impact factor: 3.580

8.  Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction.

Authors:  Djamel Messaad; Hocine Sahla; Said Benahmed; Philippe Godard; Jean Bousquet; Pascal Demoly
Journal:  Ann Intern Med       Date:  2004-06-15       Impact factor: 25.391

Review 9.  The lymphocyte transformation test in the diagnosis of drug hypersensitivity.

Authors:  W J Pichler; J Tilch
Journal:  Allergy       Date:  2004-08       Impact factor: 13.146

Review 10.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

Authors:  Harold R Collard; Christopher J Ryerson; Tamera J Corte; Gisli Jenkins; Yasuhiro Kondoh; David J Lederer; Joyce S Lee; Toby M Maher; Athol U Wells; Katerina M Antoniou; Juergen Behr; Kevin K Brown; Vincent Cottin; Kevin R Flaherty; Junya Fukuoka; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Martin Kolb; David A Lynch; Jeffrey L Myers; Ganesh Raghu; Luca Richeldi; Hiroyuki Taniguchi; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.